Literature DB >> 9324290

Quantitative analysis of Op18 phosphorylation in childhood acute leukemia.

R Melhem1, N Hailat, R Kuick, S M Hanash.   

Abstract

Oncoprotein 18 (Op18) is a major cystolic phosphoprotein constituent of leukemia cells. There is cumulative evidence that suggests a role for Op18 in integrating signals from diverse pathways involved in cell growth. Op18 phosphorylation is induced with proliferation in a variety of cell types, and is essential for cell cycle progression. In this study we analyzed the level of unphosphorylated Op18 and of its major phosphorylated forms, Op18a and Op18b, in a series of 177 childhood acute leukemias by means of quantitative two-dimensional polyacrylamide gel electrophoresis (2-D PAGE). Op18 phosphorylation was significantly correlated with the white blood count at the time of diganosis, and with a high percentage of cells in the S phase. Our findings suggest that strategies to inhibit Op18 expression or phosphorylation may be effective in inhibiting leukemia cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9324290     DOI: 10.1038/sj.leu.2400792

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  7 in total

1.  The microtubule cytoskeleton is required for a G2 cell cycle delay in cancer cells lacking stathmin and p53.

Authors:  Bruce K Carney; Victoria Caruso Silva; Lynne Cassimeris
Journal:  Cytoskeleton (Hoboken)       Date:  2012-03-29

2.  Expression of stathmin/op18 as a significant prognostic factor for cervical carcinoma patients.

Authors:  Wang Xi; Wang Rui; Lin Fang; Dong Ke; Gao Ping; Zhang Hui-Zhong
Journal:  J Cancer Res Clin Oncol       Date:  2008-11-26       Impact factor: 4.553

3.  Overexpression of stathmin 1 is associated with poor prognosis of patients with gastric cancer.

Authors:  Bin Ke; Liang-Liang Wu; Ning Liu; Ru-Peng Zhang; Chang-Li Wang; Han Liang
Journal:  Tumour Biol       Date:  2013-06-13

4.  Stathmin 1 inhibition amplifies ruxolitinib-induced apoptosis in JAK2V617F cells.

Authors:  João Agostinho Machado-Neto; Paula de Melo Campos; Patricia Favaro; Mariana Lazarini; Adriana da Silva Santos Duarte; Irene Lorand-Metze; Fernando Ferreira Costa; Sara Teresinha Olalla Saad; Fabiola Traina
Journal:  Oncotarget       Date:  2015-10-06

5.  Paclitaxel induces Stathmin 1 phosphorylation, microtubule stability and apoptosis in acute lymphoblastic leukemia cells.

Authors:  João Agostinho Machado-Neto; Ana Paula Nunes Rodrigues Alves; Jaqueline Cristina Fernandes; Juan Luiz Coelho-Silva; Renata Scopim-Ribeiro; Bruna Alves Fenerich; Fernanda Borges da Silva; Priscila Santos Scheucher; Belinda Pinto Simões; Eduardo Magalhães Rego; Fabiola Traina
Journal:  Heliyon       Date:  2017-09-28

6.  Discovery and identification of potential biomarkers of pediatric acute lymphoblastic leukemia.

Authors:  Linan Shi; Jun Zhang; Peng Wu; Kai Feng; Jing Li; Zhensheng Xie; Peng Xue; Tanxi Cai; Ziyou Cui; Xiulan Chen; Junjie Hou; Jianzhong Zhang; Fuquan Yang
Journal:  Proteome Sci       Date:  2009-03-16       Impact factor: 2.480

Review 7.  Stathmin 1 in normal and malignant hematopoiesis.

Authors:  João Agostinho Machado-Neto; Sara Teresinha Olalla Saad; Fabiola Traina
Journal:  BMB Rep       Date:  2014-12       Impact factor: 4.778

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.